COVID-19
Regístrese
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Tigecycline therapy in pediatric patients with multidrug resistant bacteremia
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Original article
Tigecycline therapy in pediatric patients with multidrug resistant bacteremia
Tratamiento con tigeciclina en pacientes pediátricos con bacteriemia multirresistente
Aslinur Ozkaya-Parlakaya,
Corresponding author
aslinur.o@gmail.com

Corresponding author.
, Belgin Gulhana, Saliha Kanik-Yukseka, Dogus Guneyb, Deniz Gonulalc, Gokhan Demirtasb, Hasan Tezera, Sevim Unalc, Emrah Seneld
a Ankara Hematology Oncology Children's Training and Research Hospital, Pediatric Infectious Disease Department, Ankara, Turkey
b Ankara Hematology Oncology Children's Training and Research Hospital, Pediatric Surgery and Burn Unit, Ankara, Turkey
c Ankara Hematology Oncology Children's Training and Research Hospital, Neonatology Department, Ankara, Turkey
d Yıldırım Beyazıt University, Pediatric Surgery and Burn Unit, Ankara, Turkey
Read
1990
Times
was read the article
564
Total PDF
1426
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2019.12.018
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 14 19 33
2024 March 67 28 95
2024 February 45 9 54
2024 January 45 12 57
2023 December 44 19 63
2023 November 57 41 98
2023 October 74 44 118
2023 September 33 17 50
2023 August 33 2 35
2023 July 27 35 62
2023 June 34 8 42
2023 May 40 1 41
2023 April 16 4 20
2023 March 86 6 92
2023 February 30 13 43
2023 January 32 7 39
2022 December 24 9 33
2022 November 36 15 51
2022 October 27 18 45
2022 September 23 13 36
2022 August 32 19 51
2022 July 24 9 33
2022 June 28 21 49
2022 May 39 13 52
2022 April 26 17 43
2022 March 36 11 47
2022 February 33 16 49
2022 January 62 8 70
2021 December 28 20 48
2021 November 34 12 46
2021 October 48 24 72
2021 September 30 20 50
2021 August 48 10 58
2021 July 29 8 37
2021 June 32 7 39
2021 May 9 0 9
2021 March 2 2 4
2021 February 5 4 9
2021 January 19 2 21
2020 December 75 21 96
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica
Special content about COVID-19
Free access articles
Executive summary of the consensus document on the shared...
Enferm Infecc Microbiol Clin. 2024;42:102-7
Executive Summary of the Consensus Statement of the Spanish...
Enferm Infecc Microbiol Clin. 2020;38:283-8
SARS-CoV-2 infection as trigger multisystem inflammatory...
Enferm Infecc Microbiol Clin. 2021;39:262-4


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos